• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限性皮肤型硬皮病:一例报告

Limited Cutaneous Scleroderma: A Case Report.

作者信息

Marathe Manvi, Borkar Shweta

机构信息

Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

Internal Medicine, Datta Meghe Medical College, Nagpur, IND.

出版信息

Cureus. 2023 Sep 16;15(9):e45336. doi: 10.7759/cureus.45336. eCollection 2023 Sep.

DOI:10.7759/cureus.45336
PMID:37849593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577515/
Abstract

Scleroderma is an uncommon disease that affects the connective tissue, causing skin hardening and sometimes organ damage. There are two main forms of scleroderma: localised scleroderma, or morphea, which usually has a mild and limited course and only affects the skin and/or the tissues below it, and systemic sclerosis, which involves skin hardening and internal organ problems. The cause of localised scleroderma is unknown. Recent studies suggest that this form can have different levels of severity and can affect some organs. To avoid complications due to the high morbidity of localised scleroderma, early treatment is recommended. In this article, we present the main aspects and details of the management of patients with localised scleroderma.

摘要

硬皮病是一种罕见的疾病,会影响结缔组织,导致皮肤硬化,有时还会造成器官损害。硬皮病主要有两种类型:局限性硬皮病,即硬斑病,通常病程较轻且有限,仅影响皮肤和/或其下方的组织;以及系统性硬化症,会涉及皮肤硬化和内脏器官问题。局限性硬皮病的病因尚不清楚。最近的研究表明,这种类型可能有不同程度的严重程度,并且会影响一些器官。为避免因局限性硬皮病的高发病率而引发并发症,建议尽早治疗。在本文中,我们介绍了局限性硬皮病患者管理的主要方面和细节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/a21c928ba457/cureus-0015-00000045336-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/db51f6e4c046/cureus-0015-00000045336-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/2444e39a04b1/cureus-0015-00000045336-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/6857a224b8f2/cureus-0015-00000045336-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/a21c928ba457/cureus-0015-00000045336-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/db51f6e4c046/cureus-0015-00000045336-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/2444e39a04b1/cureus-0015-00000045336-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/6857a224b8f2/cureus-0015-00000045336-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5816/10577515/a21c928ba457/cureus-0015-00000045336-i04.jpg

相似文献

1
Limited Cutaneous Scleroderma: A Case Report.局限性皮肤型硬皮病:一例报告
Cureus. 2023 Sep 16;15(9):e45336. doi: 10.7759/cureus.45336. eCollection 2023 Sep.
2
Systemic Sclerosis (Scleroderma)系统性硬化症(硬皮病)
3
Localized scleroderma: clinical spectrum and therapeutic update.局限性硬皮病:临床谱与治疗进展
An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890.
4
[Diagnostic and therapeutic problems of scleroderma].[硬皮病的诊断与治疗问题]
Wiad Lek. 2006;59(5-6):392-5.
5
Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.硬皮病和硬皮病样疾病的皮肤表现:全面综述。
Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. doi: 10.1007/s12016-017-8625-4.
6
Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.硬皮病:命名、病因、发病机制、预后和治疗:事实和争议。
Clin Dermatol. 2013 Jul-Aug;31(4):432-437. doi: 10.1016/j.clindermatol.2013.01.010.
7
Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.维甲酸治疗系统性硬化症和硬斑病:文献综述
Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12455. Epub 2016 Dec 29.
8
Caring for the Patient With Limited Systemic Scleroderma.照料局限性系统性硬化症患者。
Orthop Nurs. 2016 Jan-Feb;35(1):5-10; quiz 11-2. doi: 10.1097/NOR.0000000000000212.
9
Scleroderma and dentistry: Two case reports.硬皮病与牙科:两例病例报告。
J Med Case Rep. 2016 Oct 24;10(1):297. doi: 10.1186/s13256-016-1086-1.
10
Scleroderma and scleroderma-like syndromes.硬皮病及硬皮病样综合征。
Front Immunol. 2024 Jun 3;15:1351675. doi: 10.3389/fimmu.2024.1351675. eCollection 2024.

本文引用的文献

1
Localized scleroderma: actual insights and new biomarkers.局限性硬皮病:实际见解与新生物标志物
Int J Dermatol. 2022 Jun;61(6):667-674. doi: 10.1111/ijd.15811. Epub 2021 Aug 4.
2
Morphea: a practical review of its diagnosis, classification and treatment.硬斑病:关于其诊断、分类及治疗的实用综述
Gac Med Mex. 2019;155(5):483-491. doi: 10.24875/GMM.M20000336.
3
Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma.甲氨蝶呤耐药性幼年局限性硬皮病的临床特征。
Acta Derm Venereol. 2019 May 1;99(6):539-543. doi: 10.2340/00015555-3155.
4
Scleroderma in children.儿童硬皮病。
Best Pract Res Clin Rheumatol. 2017 Aug;31(4):576-595. doi: 10.1016/j.berh.2018.02.004. Epub 2018 Mar 27.
5
Systemic sclerosis.系统性硬化症。
Lancet. 2017 Oct 7;390(10103):1685-1699. doi: 10.1016/S0140-6736(17)30933-9. Epub 2017 Apr 13.
6
Localized scleroderma: clinical spectrum and therapeutic update.局限性硬皮病:临床谱与治疗进展
An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890.
7
Morphea (localized scleroderma).硬斑病(局限性硬皮病)。
JAMA Dermatol. 2013 Sep;149(9):1124. doi: 10.1001/jamadermatol.2013.5079.
8
Localized scleroderma.局限性硬皮病。
Dermatol Ther. 2012 Mar-Apr;25(2):135-47. doi: 10.1111/j.1529-8019.2012.01479.x.
9
The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies.系统性红斑狼疮女性发病率高于男性的原因不明:遗传和细胞因子研究的线索。
Clin Rev Allergy Immunol. 2011 Feb;40(1):42-9. doi: 10.1007/s12016-009-8192-4.
10
[Juvenile scleroderma].[青少年硬皮病]
Acta Reumatol Port. 2008 Jul-Sep;33(3):289-97.